Investigational Site Number : 1000007

Pazardzhik 4400

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis

Studies at this site

• Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis — Running, not enrolling
• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling